CPhI expert calls for urgent regulatory change
17 September 2015 | By
CPhI expert, Girish Malhotra calls for a radical solution to improve pharma manufacturing processes in his thought provoking piece...
List view / Grid view
News
FDA approves asthma treatment Spiriva Respimat
16 September 2015 | By Victoria White
It is approved by the FDA for the long-term, once-daily, maintenance treatment of asthma in patients 12 years of age and older...
Sirius inForm to be used by leading research group at Purdue University
16 September 2015 | By Sirius Analytical
The Sirius inForm measures the kinetics of dissolution, absorption, controlled supersaturation and precipitation, and accommodates multiple dosage forms and sample types...
Comark Instruments introduces M9 software upgrade for RF500 monitoring solution
16 September 2015 | By Comark Instruments
With delivering best-in-class Temperature Monitoring solutions and a desire for continuous improvement as primary focuses, Comark Instruments has announced the release of a new software upgrade for the well-established RF500 Monitoring System...
HPLC Congress 2016- Exploring the boundless analytical techniques
16 September 2015 | By HPLC
Microanalysis which is critical in today’s research is ushered by boundless analytical techniques, the major one being HPLC...
Breakthrough Therapy Designation for Opdivo in renal cell carcinoma
16 September 2015 | By Victoria White
The designation is based on results of CheckMate -025, a Phase 3 study that evaluated the survival of patients with previously treated advanced or metastatic clear-cell RCC versus everolimus...
Open dialogue could improve type 2 diabetes management
16 September 2015 | By Victoria White
Results from a new study showed different perceptions of control among physicians and patients that may lead to suboptimal type 2 diabetes management...
Record sales and solid profit growth
16 September 2015 | By Bachem AG
Bachem Group increased its sales by about 15% to nearly 100 million CHF in the first half of 2015...
Janssen extends Blue Latitude contract
16 September 2015 | By Victoria White
Blue Latitude has been reappointed to provide Janssen with strategic support and creative marketing services for their brand teams in the EMEA region...
Liraglutide provides greater blood sugar reduction than lixisenatide in new trial
16 September 2015 | By Victoria White
Findings from the LIRA-LIXI trial have demonstrated a significantly greater reduction in blood sugar for liraglutide compared to lixisenatide in type 2 diabetes...
FDA approves Octapharma’s Nuwiq for haemophilia A
16 September 2015 | By Victoria White
Nuwiq is the first B-domain deleted recombinant Factor VIII derived from a human cell-line designed for the treatment of patients with haemophilia A...
Greenovation to start Phase I clinical trial for moss-aGal
16 September 2015 | By Victoria White
Moss-aGal, a recombinant form of human alpha galactosidase, is the world´s first moss-produced drug candidate...
Abasaglar provides similar safety and efficacy to Lantus
15 September 2015 | By Victoria White
Data from secondary analyses of Phase III trials show Abasaglar (insulin glargine) demonstrated safety and efficacy outcomes similar to Lantus in diabetes...
Tresiba U200 delivers lower rates of hypoglycaemia
15 September 2015 | By Victoria White
Data show that Tresiba U200 significantly lowers both rates of hypoglycaemia and mean fasting blood glucose compared to insulin glargine U100 in patients with type 2 diabetes...
GW announces positive top line results for CBD in schizophrenia
15 September 2015 | By Victoria White
The addition of Cannabidiol (CBD)to the medication of patients who were only partially responsive to standard treatment produced significant improvements in outcome measures...
